Pelthos Therapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Pelthos Therapeutics stock has a target of 50, which predicts a 47.93% increase from the current stock price of 33.80.

Price Target: $50.00 (+47.93%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$50	$50	$50	$50
Change	+47.93%	+47.93%	+47.93%	+47.93%

Analyst Ratings

According to 1 stock analyst, the rating for Pelthos Therapeutics is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Sep '25
Strong Buy	0
Buy	1
Hold	0
Sell	0
Strong Sell	0
Total	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jeff Jones Oppenheimer	Oppenheimer	Buy Initiates $50	Buy	Initiates	$50	+47.93%	Sep 2, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

8.88M

Revenue Next Year

32.21M

from 8.88M

262.88%

from 8.88M

EPS This Year

-2.60

from -14.27

EPS Next Year

-1.58

from -2.60

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	199.93K	-	-	-	-	8.88M	32.21M
Revenue Growth	-	-	-	-	-	-	262.88%
EPS	-	-	-56.48	-57.82	-14.27	-2.60	-1.58
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	12.4M	38.4M
Avg	8.9M	32.2M
Low	5.5M	26.0M

Revenue Growth

Revenue Growth	2025	2026
High	-	332.9%
Avg	-	262.9%
Low	-	193.3%

EPS Forecast

EPS	2025	2026
High	-2.68	-0.74
Avg	-2.60	-1.58
Low	-2.50	-2.35

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.